z-logo
open-access-imgOpen Access
Alectinib rescue therapy in advanced ALK rearranged lung adenocarcinoma: a case report
Author(s) -
Cristiano Cesaro,
Umberto Caterino,
Fabio Perrotta,
Umberto Masi,
Alessandra Cotroneo,
Roberta Cianci,
Enzo Zamparelli,
Flavio Cesaro,
Dario Amore,
Danilo Rocco
Publication year - 2022
Publication title -
monaldi archives for chest disease
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.196
H-Index - 46
eISSN - 2465-101X
pISSN - 1122-0643
DOI - 10.4081/monaldi.2022.2388
Subject(s) - alectinib , crizotinib , medicine , anaplastic lymphoma kinase , lung cancer , alk inhibitor , adenocarcinoma , oncology , malignant pleural effusion , pleural effusion , targeted therapy , tyrosine kinase inhibitor , chemotherapy , cancer research , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom